Spectroscopic Analysis of an Antimalarial Drug’s (Quinine) Influence on Human Serum Albumin Reduction and Antioxidant Potential
Abstract
:1. Introduction
2. Results and Discussion
2.1. The Spectroscopic Analysis of Qi-HSA Interaction
2.2. The Analysis of Qi and HSA’s Antioxidant Activity
3. Materials and Methods
3.1. Reagents and Chemicals
3.2. Methods
3.2.1. Emission and Absorption Spectra Measurements
3.2.2. Circular Dichroism (CD) Measurements
3.2.3. Interaction Ligand–Protein Analysis
3.2.4. Reduction and Antioxidant Potential Analysis
3.3. Statistics
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Achan, J.; Talisuna, A.O.; Erhart, A.; Yeka, A.; Tibenderana, J.K.; Baliraine, F.N.; Rosenthal, P.J.; D’Alessandro, U. Quinine, an old anti-malarial rug in a modern world: Role in the treatment of malaria. Malar. J. 2011, 10, 144. [Google Scholar] [CrossRef] [PubMed]
- Jones, R.A.; Panda, S.S.; Hall, C.D. Quinine conjugates and quinine analogues as potential antimalarial agents. Eur. J. Med. Chem. 2015, 97, 335–355. [Google Scholar] [CrossRef]
- Permin, H.; Norn, S.; Kruse, E.; Kruse, P.R. On the history of Cinchona bark in the treatment of Malaria. Dan. Medicinhist. Arbog. 2016, 44, 9–30. [Google Scholar] [PubMed]
- Rogerson, S.J. Management of malaria in pregnancy. Indian J. Med. Res. 2017, 146, 328–333. [Google Scholar] [CrossRef] [PubMed]
- Lalloo, D.G.; Shingadia, D.; Bell, D.J.; Beeching, N.J.; Whitty, C.J.M.; Chiodini, P.L.; PHE Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines 2016. J. Infect. 2016, 72, 635–649. [Google Scholar] [CrossRef]
- Kehrer, J.P.; Klotz, L.O. Free radicals and related reactive species as mediators of tissue injury and disease: Implications for Health. Crit. Rev. Toxicol. 2015, 45, 765–798. [Google Scholar] [CrossRef]
- Greve, B.; Lehman, L.G.; Lell, B.; Luckner, D.; Schmidt-Ott, R.; Kremsner, P.G. High oxygen radical production is associat-ed with fast parasite clearance in children with Plasmodium falciparum malaria. J. Infect. Dis. 1999, 179, 1584–1586. [Google Scholar] [CrossRef]
- Kharazmi, A.; Jepsen, S.; Andersen, B.J. Generation of reactive oxygen radicals by human phagocytic cells activated by Plasmodium falciparum. Scand. J. Immunol. 1987, 25, 335–341. [Google Scholar] [CrossRef]
- Jones, D.P. Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol. 2008, 295, C849–C868. [Google Scholar] [CrossRef]
- Alkadi, H. A Review on Free Radicals and Antioxidants. Infect. Disord. Drug Targets 2020, 20, 16–26. [Google Scholar] [CrossRef]
- Arques, S. Albumine sérique et maladies cardiovasculaires: Une revue approfondie de la littérature [Serum albumin and cardiovascular diseases: A comprehensive review of the literature. Ann. Cardiol. Angeiol. 2018, 67, 82–90. (In French) [Google Scholar] [CrossRef] [PubMed]
- Wanwimolruk, S.; Denton, J.R. Plasma protein binding of quinine: Binding to human serum albumin, alpha 1-acid gly-coprotein and plasma from patients with malaria. J. Pharm. Pharmacol. 1992, 44, 806–811. [Google Scholar] [CrossRef] [PubMed]
- Olszowy-Tomczyk, M. Synergistic, antagonistic and additive antioxidant effects in the binary mixtures. Phytochem. Rev. 2020, 19, 63–103. [Google Scholar] [CrossRef]
- Lushchak, V.I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 2014, 224, 164–175. [Google Scholar] [CrossRef]
- Gebicki, J.M. Oxidative stress, free radicals and protein peroxides. Arch. Biochem. Biophys. 2016, 595, 33–39. [Google Scholar] [CrossRef] [PubMed]
- Soriani, M.; Pietraforte, D.; Minetti, M. Antioxidant potential of anaerobic human plasma: Role of serum albumin and thiols as scavengers of carbon radicals. Arch. Biochem. Biophys. 1994, 312, 180–188. [Google Scholar] [CrossRef]
- Anraku, M.; Chuang, V.T.; Maruyama, T.; Otagiri, M. Redox properties of serum albumin. Biochim. Biophys. Acta 2013, 1830, 5465–5472. [Google Scholar] [CrossRef]
- Fanali, G.; di Masi, A.; Trezza, V.; Marino, M.; Fasano, M.; Ascenzi, P. Human serum albumin: From bench to bedside. Mol. Aspects Med. 2012, 33, 209–290. [Google Scholar] [CrossRef]
- Plantier, J.L.; Duretz, V.; Devos, V.; Urbain, R.; Jorieux, S. Comparison of antioxidant properties of different therapeutic albumin preparations. Biologicals 2016, 44, 226–233. [Google Scholar] [CrossRef]
- Maciążek-Jurczyk, M.; Sułkowska, A. Spectroscopic analysis of the impact of oxidative stress on the structure of human serum albumin (HSA) in terms of its binding properties. Spectrochim. Acta A Mol Biomol. Spectrosc. 2015, 136 Pt B, 265–282. [Google Scholar] [CrossRef]
- Li, X.; Chen, D.; Wang, G.; Lu, Y. Study of interaction between human serum albumin and three antioxidants: Ascorbic acid, α-tocopherol, and proanthocyanidins. Eur. J. Med. Chem. 2013, 70, 22–36. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.; Cha, M.K.; Kim, I.H. Activation of thiol-dependent antioxidant activity of human serum albumin by alkaline pH is due to the B-like conformational change. Arch. Biochem. Biophys. 2000, 380, 309–318. [Google Scholar] [CrossRef] [PubMed]
- Vieira, J.L.F.; Borges, L.M.G.; Nascimento, M.T.S.; de Gomes, A.L.S. Quinine levels in patients with uncomplicated fal-ciparum malaria in the Amazon region of Brazil. Quinine levels in patients with uncomplicated falciparum malaria in the Ama-zon region of Brazil. Braz. J. Infect. Dis. 2008, 12, 353–354. [Google Scholar] [CrossRef] [PubMed]
- Valko, M.; Jomova, K.; Rhodes, C.J.; Kuča, K.; Musílek, K. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch. Toxicol. 2016, 90, 1–37. [Google Scholar] [CrossRef]
- Al-Harthi, S.; Lachowicz, J.I.; Nowakowski, M.E.; Jaremko, M.; Jaremko, Ł. Towards the functional high-resolution co-ordination chemistry of blood plasma human serum albumin. J. Inorg. Biochem. 2019, 198, 110716. [Google Scholar] [CrossRef]
- McCloskey, K.L.; Garriott, J.C.; Roberts, S.M. Quinine Concentrations in Blood Following the Consumption of Gin and Tonic Preparations in a Social Setting. J. Anal. Toxicol. 1978, 2, 110–112. [Google Scholar] [CrossRef]
- Silamut, K.; White, N.J.; Looareesuwan, S.; Warrell, D.A. Binding of quinine to plasma proteins in falciparum malaria. Am. J. Trop. Med. Hyg. 1985, 34, 681–686. [Google Scholar] [CrossRef]
- Dyer, J.R.; Davis, T.M.; Giele, C.; Annus, T.; Garcia-Webb, P.; Robson, J. The pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly. Br. J. Clin. Pharmacol. 1994, 38, 205–212. [Google Scholar] [CrossRef]
- Pukrittayakamee, S.; Wanwimolruk, S.; Stepniewska, K.; Jantra, A.; Huyakorn, S.; Looareesuwan, S.; White, N.J. Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 2003, 47, 3458–3463. [Google Scholar] [CrossRef]
- Ren, G.; Sun, H.; Guo, J.; Fan, J.; Li, G.; Xu, S. Molecular mechanism of the interaction between resveratrol and trypsin via spectroscopy and molecular docking. Food Funct. 2019, 10, 3291–3302. [Google Scholar] [CrossRef]
- Suhartono, E.; Thalib, I.; Aflanie, I.; Noor, Z.; Idroes, R. Study of Interaction between Cadmium and Bovine Serum Al-bumin with UV-Vis Spectrocopy Approach. IOP Conf. Ser. Mater. Sci. Eng. 2018, 350, 012008. [Google Scholar] [CrossRef]
- Frostell-Karlsson, A.; Remaeus, A.; Roos, H.; Andersson, K.; Borg, P.; Hämäläinen, M.; Karlsson, R. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J. Med. Chem. 2000, 43, 1986–1992. [Google Scholar] [CrossRef] [PubMed]
- Bougie, D.W.; Wilker, P.R.; Aster, R.H. Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies. Blood 2006, 108, 922–927. [Google Scholar] [CrossRef] [PubMed]
- Marszałł, M.P.; Buciński, A. A protein-coated magnetic beads as a tool for the rapid drug-protein binding study. J. Pharm. Biomed. Anal. 2010, 52, 420–424. [Google Scholar] [CrossRef]
- Liu, Y.; Chen, M.; Wang, S.; Lin, J.; Cai, L.; Song, L. New insight into the stereoselective interactions of quinine and quinidine, with bovine serum albumin. J. Mol. Recognit. 2014, 27, 239–249. [Google Scholar] [CrossRef]
- Day, Y.S.N.; Myszka, D.G. Characterizing a Drug’s Primary Binding Site on Albumin. J. Pharm. Sci. 2003, 92, 333–343. [Google Scholar] [CrossRef] [PubMed]
- Kratochwil, N.A.; Huber, W.; Müller, F.; Kansy, M.; Gerber, P.R. Predicting plasma protein binding of drugs: A new ap-proach. Biochem. Pharmacol. 2002, 64, 1355–1374. [Google Scholar] [CrossRef]
- Sudlow, G.; Birkett, D.J.; Wade, D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 1975, 11, 824–832. [Google Scholar]
- Paubel, J.P.; Niviere, P. Bonding of therapeutic organic molecules with proteins quinine. Eur. J. Med. Chem. 1974, 9, 508–512. [Google Scholar]
- Greenfield, N.J. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 2006, 1, 2876–2890. [Google Scholar] [CrossRef]
- Venyaminov, S.Y.; Vassilenko, K.S. Determination of protein tertiary structure class from circular dichroism spectra. Anal. Biochem. 1994, 222, 176–184. [Google Scholar] [CrossRef] [PubMed]
- Kelly, S.M.; Jess, T.J.; Price, N.C. How to study proteins by circular dichroism. Biochim. Biophys. Acta 2005, 1751, 119–139. [Google Scholar] [CrossRef] [PubMed]
- Kelly, S.M.; Price, N.C. The use of circular dichroism in the investigation of protein structure and function. Curr. Protein Pept. Sci. 2000, 1, 349–384. [Google Scholar] [CrossRef] [PubMed]
- Chudzik, M.; Maciążek-Jurczyk, M.; Pawełczak, B.; Sułkowska, A. Spectroscopic Studies on the Molecular Ageing of Se-rum Albumin. Molecules 2016, 22, 34. [Google Scholar] [CrossRef] [PubMed]
- Szkudlarek, A.; Pentak, D.; Ploch, A.; Pożycka, J.; Maciążek-Jurczyk, M. In Vitro Investigation of the Interaction of Tol-butamide and Losartan with Human Serum Albumin in Hyperglycemia States. Molecules 2017, 22, 2249. [Google Scholar] [CrossRef]
- Maciążek-Jurczyk, M.; Janas, K.; Pożycka, J.; Szkudlarek, A.; Rogóż, W.; Owczarzy, A.; Kulig, K. Human Serum Albumin Aggregation/Fibrillation and its Abilities to Drugs Binding. Molecules 2020, 25, 618. [Google Scholar] [CrossRef]
- Bocedi, A.; Cattani, G.; Stella, L.; Massoud, R.; Ricci, G. Thiol disulfide exchange reactions in human serum albumin: The apparent paradox of the redox transitions of Cys34. FEBS J. 2018, 285, 3225–3237. [Google Scholar] [CrossRef]
- Jovanović, V.B.; Pavićević, I.D.; Takić, M.M.; Penezić-Romanjuk, A.Z.; Aćimović, J.M.; Mandić, L.M. The influence of fatty acids on determination of human serum albumin thiol group. Anal. Biochem. 2014, 448, 50–57. [Google Scholar] [CrossRef]
- Uzelac, T.N.; Nikolić-Kokić, A.L.; Spasić, S.D.; Mačvanin, M.T.; Nikolić, M.R.; Mandić, L.M.; Jovanović, V.B. Opposite clozapine and ziprasidone effects on the reactivity of plasma albumin SH-group are the consequence of their different binding properties dependent on protein fatty acids content. Chem. Biol. Interact. 2019, 311, 108787. [Google Scholar] [CrossRef]
- Takić, M.M.; Jovanović, V.B.; Pavićević, I.D.; Uzelac, T.N.; Aćimović, J.M.; Ristić-Medić, D.K.; Mandić, L.M. Binding of enterolactone and enterodiol to human serum albumin: Increase of cysteine-34 thiol group reactivity. Food Funct. 2016, 7, 1217–1226. [Google Scholar] [CrossRef]
- Zaidi, N.; Ahmad, E.; Rehan, M.; Rabbani, G.; Ajmal, M.R.; Zaidi, Y.; Subbarao, N.; Khan, R.H. Biophysical insight into furosemide binding to human serum albumin: A study to unveil its impaired albumin binding in uremia. J. Phys. Chem. B 2013, 117, 2595–2604. [Google Scholar] [CrossRef] [PubMed]
- Owczarzy, A.; Zięba, A.; Pożycka, J.; Kulig, K.; Rogóż, W.; Szkudlarek, A.; Maciążek-Jurczyk, M. Spectroscopic Studies of Quinobenzothiazine Derivative in Terms of the In Vitro Interaction with Selected Human Plasma Proteins. Part 1. Molecules 2021, 26, 4776. [Google Scholar] [CrossRef]
- Zhu, M.; Wang, L.; Wang, Y.; Zhou, J.; Ding, J.; Li, W.; Xin, Y.; Fan, S.; Wang, Z.; Wang, Y. Biointeractions of Herbicide Atrazine with Human Serum Albumin: UV-Vis, Fluorescence and Circular Dichroism Approaches. Int. J. Environ. Res. Public Health 2018, 15, 116. [Google Scholar] [CrossRef] [PubMed]
- Yuan, L.; Liu, M.; Liu, G.; Li, D.; Wang, Z.; Wang, B.; Han, J.; Zhang, M. Competitive binding of (-)-epigallocatechin-3-gallate and 5-fluorouracil to human serum albumin: A fluorescence and circular dichroism study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2017, 173, 584–592. [Google Scholar] [CrossRef] [PubMed]
- Duman, O.; Tunç, S.; Kancı Bozoğlan, B. Characterization of the binding of metoprolol tartrate and guaifenesin drugs to human serum albumin and human hemoglobin proteins by fluorescence and circular dichroism spectroscopy. J. Fluoresc. 2013, 23, 659–669. [Google Scholar] [CrossRef]
- Mohammadi, F.; Bordbar, A.K.; Divsalar, A.; Mohammadi, K.; Saboury, A.A. Analysis of binding interaction of curcu-min and diacetylcurcumin with human and bovine serum albumin using fluorescence and circular dichroism spectroscopy. Protein J. 2009, 28, 189–196. [Google Scholar] [CrossRef]
- Messina, P.; Prieto, G.; Dodero, V.; Ruso, J.M.; Schulz, P.; Sarmiento, F. Ultraviolet-circular dichroism spectroscopy and potentiometric study of the interaction between human serum albumin and sodium perfluorooctanoate. Biopolymers 2005, 79, 300–309. [Google Scholar] [CrossRef]
- Liu, Y.; Chen, M.; Jiang, L.; Song, L. Stereoselective interaction of cinchona alkaloid isomers with bovine serum albu-min. Food Chem. 2015, 181, 170–178. [Google Scholar] [CrossRef]
- Guimarães, R.; Barros, L.; Carvalho, A.M.; Ferreira, I.C. Infusions and decoctions of mixed herbs used in folk medicine: Synergism in antioxidant potential. Phytother. Res. 2011, 25, 1209–1214. [Google Scholar] [CrossRef]
- Guimarães, R.; Barreira, J.C.M.; Barros, L.; Carvalho, A.M.; Ferreira, I.C.F.R. Effects of oral dosage forms and storage period in the antioxidant properties of four species used in traditional herbal medicine. Phytother. Res. 2011, 25, 484–492. [Google Scholar] [CrossRef]
- Cao, H.; Jia, X.; Shi, J.; Xiao, J.; Chen, X. Non-covalent interaction between dietary stilbenoids and human serum albu-min: Structure-affinity relationship, and its influence on the stability, free radical scavenging activity and cell uptake of stil-benoids. Food Chem. 2016, 202, 383–388. [Google Scholar] [CrossRef] [PubMed]
- Arcanjo, N.M.O.; Luna, C.; Madruga, M.S.; Estévez, M. Antioxidant and pro-oxidant actions of resveratrol on human se-rum albumin in the presence of toxic diabetes metabolites: Glyoxal and methyl-glyoxal. Biochim. Biophys. Acta Gen. Subj. 2018, 1862, 1938–1947. [Google Scholar] [CrossRef] [PubMed]
- Cao, H.; Chen, X.; Yamamoto, K. Bovine serum albumin significantly improves the DPPH free radical scavenging po-tential of dietary polyphenols and gallic acids. Anticancer Agents Med. Chem. 2012, 12, 940–948. [Google Scholar] [CrossRef]
- Zhang, Y.; Wu, S.; Qin, Y.; Liu, J.; Liu, J.; Wang, Q.; Ren, F.; Zhang, H. Interaction of phenolic acids and their derivatives with human serum albumin: Structure-affinity relationships and effects on antioxidant activity. Food Chem. 2018, 240, 1072–1080. [Google Scholar] [CrossRef]
- Du, S.; Xie, Y.; Chen, X. Influence of glucose on the human serum albumin-flavone interaction and their antioxidant activity. Mol. Biosyst. 2013, 9, 55–60. [Google Scholar] [CrossRef] [PubMed]
- Sakata, N.; Moh, A.; Takebayashi, S. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Heart Vessels 2002, 17, 22–29. [Google Scholar] [CrossRef] [PubMed]
- Suo, Z.; Xiong, X.; Sun, Q.; Zhao, L.; Tang, P.; Hou, Q.; Zhang, Y.; Wu, D.; Li, H. Investigation on the Interaction of Dabrafenib with Human Serum Albumin Using Combined Experiment and Molecular Dynamics Simulation: Exploring the Binding Mechanism, Esterase-like Activity, and Antioxidant Activity. Mol. Pharm. 2018, 15, 5637–5645. [Google Scholar] [CrossRef]
- Almajano, M.P.; Delgado, M.E.; Gordon, M.H. Changes in the antioxidant properties of protein solutions in the presence of epigallocatechin gallate. Food Chem. 2007, 101, 126–130. [Google Scholar] [CrossRef]
- Bae, M.J.; Ishii, T.; Minoda, K.; Kawada, Y.; Ichikawa, T.; Mori, T.; Kamihira, M.; Nakayama, T. Albumin stabilizes (-)-epigallocatechin gallate in human serum: Binding capacity and antioxidant property. Mol. Nutr. Food Res. 2009, 53, 709–715. [Google Scholar] [CrossRef]
- Adeniyi, O.S.; Makinde, O.V.; Friday, E.T.; Olaleye, S.B. Effects of quinine on gastric ulcer healing in Wistar rats. J. Complement. Integr. Med. 2017, 14, 1. [Google Scholar] [CrossRef]
- Gbotolorun, S.C.; Inikori, O.; Bamisi, O.D.; Osinubi, A.A.A.; Okanlawon, A.O. Quinine inhibits ovulation and produces oxidative stress in the ovary of cyclic Sprague-Dawley rats. Afr. Health Sci. 2018, 18, 253–259. [Google Scholar] [CrossRef] [PubMed]
- Milugo, T.K.; Omosa, L.K.; Ochanda, J.O.; Owuor, B.O.; Wamunyokoli, F.A.; Oyugi, J.O.; Ochieng, J.W. Antagonistic ef-fect of alkaloids and saponins on bioactivity in the quinine tree (Rauvolfia caffra sond.): Further evidence to support biotechnol-ogy in traditional medicinal plants. BMC Complement. Altern. Med. 2013, 13, 285. [Google Scholar] [CrossRef] [PubMed]
- Krishnaveni, M.; Suresh, K.; Rajasekar, M. Antioxidant and free radical scavenging activity of quinine determined by using different in vitro models. Int. J. Modn. Res. Revs. 2015, 3, 569–574. [Google Scholar]
- Krishnaveni, M.; Suresh, K. A Study on Protective Effect of Quinine against Lipid Peroxidation and Antioxidants Status in Human Oral Cancer Cell Line. Res. J. Pharm. Biol. Chem. Sci. 2015, 6, 295–301. [Google Scholar]
- Mukaka, M.M. Statistics Corner: A guide to appropriate use of Correlation coefficient in medical research. Malawi Med. J. 2012, 24, 69–71. [Google Scholar]
- Basu, P.; Maier, C. In vitro Antioxidant Activities and Polyphenol Contents of Seven Commercially Available Fruits. Pharmacogn. Res. 2016, 8, 258–264. [Google Scholar] [CrossRef]
- Suleiman, M.H.A.; Ateeg, A.A. Antimicrobial and Antioxidant Activities of Different Extracts from Different Parts of Zilla spinosa (L.) Prantl. Evid. Based Complement. Alternat. Med. 2020, 2020, 6690433. [Google Scholar] [CrossRef]
- Henríquez, C.; López-Alarcón, C.; Gómez, M.; Lutz, M.; Speisky, H. Time-dependence of ferric reducing antioxidant power (FRAP) index in Chilean apples and berries. Arch. Latinoam. Nutr. 2011, 61, 323–332. [Google Scholar]
- Li, X.; Chen, D.; Wang, G.; Lu, Y. Probing the interaction of human serum albumin with DPPH in the absence and pres-ence of the eight antioxidants. Spectrochim. Acta A Mol Biomol. Spectrosc. 2015, 137, 1144–1152. [Google Scholar] [CrossRef]
- Kirby, E.P. Fluorescence Instrumentation and Methodology, Chapter 2. In Excited States of Proteins and Nucleic Acids; Steiner, R.F., Weinryb, I., Eds.; Plenum Press: New York, NY, USA, 1971. [Google Scholar]
- Klotz, I.M.; Hunston, D.L. Protein interactions with small molecules. Relationships between stoichiometric binding constants, site binding constants, and empirical binding parameters. J. Biol. Chem. 1975, 250, 3001–3009. [Google Scholar] [CrossRef] [PubMed]
- Sreerama, N.; Woody, R.W. Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Comparison of CONTIN, SELCON, and CDSSTR Methods with an Expanded Reference. Set. Anal. Biochem. 2000, 287, 252–260. [Google Scholar] [CrossRef] [PubMed]
- Blois, M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181, 1199–1200. [Google Scholar] [CrossRef]
- Tepe, B.; Sokmen, M.; Akpulat, H.A.; Sokmen, A. In vitro antioxidant activities of the methanol extracts of four Heli-chrysum species from Turkey. Food Chem. 2005, 90, 685–689. [Google Scholar] [CrossRef]
- Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. [Google Scholar] [CrossRef]
- Biskup, I.; Golonka, I.; Gamian, A.; Sroka, Z. Antioxidant activity of selected phenols estimated by ABTS and FRAP methods. Postepy Hig. Med. Dosw. 2013, 67, 958–963. [Google Scholar] [CrossRef] [PubMed]
- Rogóż, W.; Pożycka, J.; Owczarzy, A.; Kulig, K.; Maciążek-Jurczyk, M. Comparison of Losartan and Furosemide Interaction with HSA and Their Influence on HSA Antioxidant Potential. Pharmaceuticals 2022, 15, 499. [Google Scholar] [CrossRef]
- Bersuder, P.; Hole, M.; Smith, G. Antioxidants from a heated histidine-glucose model system. I: Investigation of the an-tioxidant role of histidine and isolation of antioxidants by high-performance liquid chromatography. J. Amer. Oil Chem. Soc. 1998, 75, 181–187. [Google Scholar] [CrossRef]
- Siegei, S.; Frost, P.; Porto, F. Effects of Indoleacetic Acid and Other Oxidation Regulators on in Vitro Peroxidation and Experimental Conversion of Eugenol to Lignin. Plant Physiol. 1960, 35, 163–167. [Google Scholar] [CrossRef]
- Molyneux, P. The use of the stable free radical diphenlpicrylhydrazyl (DPPH) for estimating antioxidant activity. Songklanakarin J. Sci. Technol. 2004, 2, 211–219. [Google Scholar]
- Benzie, I.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP as-say. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef] [Green Version]
1:1 | 1:2 | 1:4 | |
---|---|---|---|
Qi measured (Qi) | 0.413 ± 0.012 | ||
Qi calculated (Qicalc) | 0.427 ± 0.011 | 0.399 ± 0.005 | 0.342 ± 0.000 |
System | Ka [M−1] ± SD * × 104 | n ± SD * |
---|---|---|
Qi-HSAcomplex | 0.952 ± 0.178 | 1.336 ± 0.274 |
System | λmin [nm] | [Θ]mrw ± SD * [deg · cm2 · dmol−1] |
---|---|---|
HSA | 209.0 | −24,774.26 ± 20.19 |
220.8 | −23,180.92 ± 19.47 | |
Qi-HSAcomplex | 209.0 | −24,214.71 ± 21.24 |
220.8 | −22,925.82 ± 12.78 |
System | % α-Helix ± SD * | % β-Sheet ± SD * | % Turn ± SD * | % Other ± SD * |
---|---|---|---|---|
HSA | 35.10 ± 0.28 | 12.25 ± 0.35 | 21.05 ± 0.35 | 31.60 ± 0.28 |
Qi-HSAcomplex | 36.25 ± 0.07 | 10.25 ± 0.07 | 21.50 ± 0.14 | 32.00 ± 0.01 |
% Inhibition ± SD * | |||||
---|---|---|---|---|---|
Time [min] | 5 | 15 | 30 | 45 | 60 |
Qi | 1.38 ± 0.75 | 1.09 ± 0.89 | 1.69 ± 1.86 | 2.45 ± 2.26 | 3.48 ± 2.62 |
HSA | 26.75 ± 0.55 | 49.11 ± 0.24 | 57.45 ± 0.24 | 62.81 ± 0.32 | 67.31 ± 1.07 |
Qi-HSAcomplex | 19.28 ± 1.10 | 33.01 ± 1.62 | 39.36 ± 1.56 | 44.07 ± 1.25 | 47.71 ± 0.53 |
AAEAC ± SD * [10−6 M AA] | |||||
---|---|---|---|---|---|
Time [min] | 5 | 15 | 30 | 45 | 60 |
Qi | 0.96 ± 0.61 | ND ** | ND ** | ND ** | ND ** |
HSA | 21.63 ± 0.44 | 40.07 ± 0.21 | 49.01 ± 0.22 | 54.40 ± 0.30 | 57.05 ± 0.99 |
Qi-HSAcomplex | 15.55 ± 0.90 | 25.95 ± 1.42 | 32.66 ± 1.41 | 36.83 ± 1.17 | 38.95 ± 0.49 |
AAERP ± SD * [10−6 M AA] | |||||
---|---|---|---|---|---|
Time [min] | 0 | 10 | 20 | 30 | 60 |
Qi | 57.70 ± 2.31 | 52.66 ± 1.79 | 46.23 ± 2.02 | 43.59 ± 1.83 | 38. 50 ± 2.32 |
HSA | 57.76 ± 2.94 | 61.74 ± 3.52 | 56.07 ± 5.12 | 56.47 ± 6.01 | 54.72 ± 8.45 |
Qi-HSAcomplex | 60.16 ± 2.25 | 64.72 ± 4.51 | 61.84 ± 5.38 | 61. 49 ± 6.70 | 59.94 ± 8.84 |
Assay | Time [min] | Qi-HSAcomplex ± SD * | Assay | Time [min] | Qi-HSAcomplex ± SD * | ||
---|---|---|---|---|---|---|---|
ABTS | 5 | Ex | 11.30 ± 0.09 | FRAP | 0 | Ex | 57.73 ± 2.57 |
De | 15.55 ± 0.90 | De | 60.16 ± 2.25 | ||||
E | s | E | a | ||||
15 | Ex | 20.04 ± 0.11 ** | 10 | Ex | 57.36 ± 2.43 | ||
De | 25.95 ± 1.42 | De | 64.72 ± 4.51 | ||||
E | s | E | s | ||||
30 | Ex | 24.60 ± 0.15 ** | 20 | Ex | 51.15 ± 3.45 | ||
De | 32.66 ± 1.41 | De | 61.84 ± 5.38 | ||||
E | s | E | s | ||||
45 | Ex | 27.24 ± 0.09 ** | 30 | Ex | 50.03 ± 3.83 | ||
De | 36.83 ± 1.17 | De | 61.49 ± 6.70 | ||||
E | s | E | s | ||||
60 | Ex | 28.67 ± 0.25 ** | 60 | Ex | 46.61 ± 5.16 | ||
De | 38.95 ± 0.49 | De | 59.94 ± 8.84 | ||||
E | s | E | s |
Assay | Sample | Linear Regression Equation | R2 | Pearson’s r Correlation Coefficient | The Nature of Correlation * |
---|---|---|---|---|---|
FRAP | Qi | y = −0.0003x + 0.0552 | 0.8983 | −0.9478 | Very high |
HSA | y = −0.00008x + 0.0592 | 0.4523 | −0.6725 | Moderate | |
Qi-HSAcomplex | y = −0.00003x + 0.0624 | 0.1605 | −0.4006 | Low |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rogóż, W.; Lemańska, O.; Pożycka, J.; Owczarzy, A.; Kulig, K.; Muhammetoglu, T.; Maciążek-Jurczyk, M. Spectroscopic Analysis of an Antimalarial Drug’s (Quinine) Influence on Human Serum Albumin Reduction and Antioxidant Potential. Molecules 2022, 27, 6027. https://doi.org/10.3390/molecules27186027
Rogóż W, Lemańska O, Pożycka J, Owczarzy A, Kulig K, Muhammetoglu T, Maciążek-Jurczyk M. Spectroscopic Analysis of an Antimalarial Drug’s (Quinine) Influence on Human Serum Albumin Reduction and Antioxidant Potential. Molecules. 2022; 27(18):6027. https://doi.org/10.3390/molecules27186027
Chicago/Turabian StyleRogóż, Wojciech, Olga Lemańska, Jadwiga Pożycka, Aleksandra Owczarzy, Karolina Kulig, Tammam Muhammetoglu, and Małgorzata Maciążek-Jurczyk. 2022. "Spectroscopic Analysis of an Antimalarial Drug’s (Quinine) Influence on Human Serum Albumin Reduction and Antioxidant Potential" Molecules 27, no. 18: 6027. https://doi.org/10.3390/molecules27186027